R
Robert H. Christenson
Researcher at University of Maryland, Baltimore
Publications - 497
Citations - 26181
Robert H. Christenson is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 77, co-authored 441 publications receiving 23846 citations. Previous affiliations of Robert H. Christenson include National Institutes of Health & Stanford University.
Papers
More filters
Journal ArticleDOI
Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia
Erik Magnus Ohman,Paul W. Armstrong,Robert H. Christenson,Christopher B. Granger,Hugo A. Katus,Christian W. Hamm,Mary Ann O'Hanesian,Galen S. Wagner,Neal S. Kleiman,Frank E. Harrell,Robert M. Califf,Eric J. Topol +11 more
TL;DR: The usefulness of base-line levels of cardiac troponin T and CK-MB and the electrocardiographic category assigned at admission and the presence of confounding factors that impair the detection of ischemia were assessed to assess the usefulness of outcome.
Journal ArticleDOI
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutiérrez,James L. Januzzi,Tamara Isakova,Karen Laliberte,Kelsey Smith,Gina Collerone,Ammar Sarwar,Udo Hoffmann,Erin Coglianese,Robert H. Christenson,Thomas J. Wang,Christopher DeFilippi,Myles Wolf +12 more
TL;DR: FGF-23 is independently associated withleft ventricular mass index and left ventricular hypertrophy in patients with CKD, and whether increased FGF- 23 is a marker or a potential mechanism of myocardial hyperTrophy in CKD requires further study.
Journal ArticleDOI
Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute
Russell V. Luepker,Fred S. Apple,Robert H. Christenson,Richard S. Crow,Stephen P. Fortmann,David C. Goff,Robert J. Goldberg,Mary M. Hand,Allan S. Jaffe,Desmond G. Julian,Daniel Levy,Teri A. Manolio,Shanthi Mendis,George A. Mensah,Andrzej Pajak,Ronald J. Prineas,K. Srinath Reddy,Véronique L. Roger,Wayne D. Rosamond,Eyal Shahar,A. Richey Sharrett,Paul D. Sorlie,Hugh Tunstall-Pedoe +22 more
TL;DR: The need for standardization of coronary heart disease (CHD) case definitions is clear, and as discussed by the authors recommends updated definitions, which are essential to epidemiological studies and other research, such as clinical trials, quality assurance, and economic analysis of healthcare costs.
Journal ArticleDOI
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
David A. Morrow,Christopher P. Cannon,Robert L. Jesse,L. Kristin Newby,Jan Ravkilde,Alan B. Storrow,Alan H.B. Wu,Robert H. Christenson +7 more
TL;DR: I. OVERVIEW of the ACUTE CORONARYSYNDROME e357A.
Journal ArticleDOI
Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults
Christopher DeFilippi,James A. de Lemos,Robert H. Christenson,John S. Gottdiener,Willem J. Kop,Min Zhan,Stephen L. Seliger +6 more
TL;DR: In this article, a longitudinal nationwide cohort study (Cardiovascular health study) was conducted to determine if cardiac troponin T (cTnT) measured by a highly sensitive assay would be detectable in the majority of community-dwelling older adults, and if serial measures were associated with risk of new-onset heart failure and cardiovascular death.